Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Adam Kohutnicki"'
Autor:
Miroslaw K. Gorny, Lucy Agyingi, Susan Zolla-Pazner, Luzia Mayr, Xiaoxin X. Wang, X Kong, Sonal Soni, Maxim Totrov, Aubin Nanfack, Michael Tuen, Liuzhe Li, Lily Liu, Yongzhao Shao, Adam Kohutnicki, Ralf Duerr
Publikováno v:
Virology. 529
The results of the RV144 vaccine clinical trial showed a correlation between high level of anti-V1V2 antibodies (Abs) and a decreased risk of acquiring HIV-1 infection. This turned the focus of HIV vaccine design to the induction of elevated levels o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba255b2051a15bc5029025af83008e3
https://pubmed.ncbi.nlm.nih.gov/30665098
https://pubmed.ncbi.nlm.nih.gov/30665098
Autor:
Liuzhe Li, Yongzhao Shao, Lucy Agyingi, X Kong, Xiaoxin X. Wang, Ralf Duerr, Lily Liu, Aubin Nanfack, Miroslaw K. Gorny, Maxim Totrov, Adam Kohutnicki, Luzia Mayr, Susan Zolla-Pazner, Sonal Soni, Michael Tuen
The positive correlation of high levels of plasma anti-V2 antibodies (Abs) with protective immunity in the Phase III anti-HIV RV144 vaccine trial generated interest in the induction of these Abs for HIV vaccine development. We analyzed plasma samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26629114f7984e6822b9b6efca81072
Autor:
Michael G. Rosenberg, Adam Kohutnicki, Joana Dobroszycki, Jorge Sansary, Jacobo Abadi, Marianne Hennessy
Publikováno v:
Open Forum Infectious Diseases. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6efb07b11976ffa06eaa51528ee98b8d
https://doi.org/10.1093/ofid/ofv133.1116
https://doi.org/10.1093/ofid/ofv133.1116